{
 "cells": [
  {
   "cell_type": "code",
   "execution_count": 1,
   "id": "87a3875b",
   "metadata": {},
   "outputs": [],
   "source": [
    "import pandas as pd\n",
    "\n",
    "def create_prompts_from_template_and_csv(template, csv_file_path):\n",
    "    \"\"\"\n",
    "    根據指定的 Prompt 模板和 CSV 檔案，生成一系列客製化的 Prompt。\n",
    "    此版本會將 Drug 和 Gene 欄位中的換行符號替換為逗號。\n",
    "\n",
    "    Args:\n",
    "        template (str): 包含 f-string 佔位符的 Prompt 模板。\n",
    "        csv_file_path (str): CSV 檔案的路徑。\n",
    "\n",
    "    Returns:\n",
    "        list: 包含所有生成 Prompt 字串的列表。\n",
    "    \"\"\"\n",
    "    all_prompts = []\n",
    "    \n",
    "    try:\n",
    "        df = pd.read_csv(csv_file_path)\n",
    "        # 清理欄位名稱，移除可能存在的前後空白\n",
    "        df.columns = df.columns.str.strip()\n",
    "    except FileNotFoundError:\n",
    "        print(f\"錯誤：找不到檔案 '{csv_file_path}'\")\n",
    "        return []\n",
    "    except KeyError as e:\n",
    "        print(f\"錯誤：CSV 檔案中缺少必要的欄位: {e}。請確保欄位名稱正確。\")\n",
    "        return []\n",
    "\n",
    "    # 迭代 CSV 中的每一行\n",
    "    for index, row in df.iterrows():\n",
    "        # 提取資料並清除值的前後空白\n",
    "        drug_name_raw = row['Drug'].strip()\n",
    "        gene_name_raw = row['Gene'].strip()\n",
    "        guideline_name = row['Guidelines'].strip()\n",
    "        \n",
    "        # --- 新增的處理步驟 ---\n",
    "        # 將字串中的換行符號 '\\n' 替換為 ', '\n",
    "        drug_name_processed = drug_name_raw.replace('\\n', ', ')\n",
    "        gene_name_processed = gene_name_raw.replace('\\n', ', ')\n",
    "        \n",
    "        # 使用 .format() 將處理過的資料填入模板末端\n",
    "        formatted_prompt = template.format(\n",
    "            csv_drug_name=drug_name_processed,\n",
    "            csv_gene_name=gene_name_processed,\n",
    "            csv_guideline_name=f\"{guideline_name}.pdf\"\n",
    "        )\n",
    "        all_prompts.append(formatted_prompt)\n",
    "        \n",
    "    return all_prompts\n"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "id": "3c65e25a",
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "成功根據最終模板生成了 28 個 Prompt 版本。\n",
      "\n",
      "--- Prompt 範例 (第 5 個版本)，檢視換行符號處理 ---\n",
      "\n",
      "## CPIC QA Dataset Generator\n",
      "You are a pharmacogenomics expert creating structured QA datasets from CPIC guidelines. Follow this protocol:\n",
      "\n",
      "#### 1. Question Generation Requirements\n",
      "- **Exclusively generate drug-gene interaction questions**\n",
      "- **Question structure**:  \n",
      "  \"How does [Gene] affect [Drug] therapy?\"  \n",
      "- **Key requirements**:  \n",
      "  - Questions MUST require CPIC guideline consultation  \n",
      "\n",
      "#### 2. Answer Format Specification\n",
      "{\n",
      "\"Drug Name\": \"[Exact drug name from guideline]\",\n",
      "\"Gene Name\": \"[Standard gene nomenclature]\",\n",
      "\"CPIC Guideline Name\": \"[Full guideline title with publication date].pdf\",\n",
      "\"Content to Search\": \"[Text specifying the missing clinical information(parameters, guidance, dosage recommendation, etc.)requiring guideline search]\"\n",
      "}\n",
      "- **Content to Search rules**:  \n",
      "  - Specify the missing clinical information(parameters, guidance, dosage recommendation, etc.)requiring guideline search and contributing to answer the question\n",
      "\n",
      "\n",
      "#### 3. Processing Workflow\n",
      "**Step 1: Process drug-gene pairs**  \n",
      "- For each combination in input lists:  \n",
      "  (Drug, Gene) → Generate QA pair\n",
      "\n",
      "**Step 2: Generate QA pairs per combination**  \n",
      "\n",
      "**Step 3: Format output**  \n",
      "{\n",
      "\"[Exact Guideline Title].pdf\": [\n",
      "{\n",
      "\"question\": \"How does CYP2C19 affect dexlansoprazole therapy?\",\n",
      "\"answer\": {\n",
      "\"Drug Name\": \"Dexlansoprazole\",\n",
      "\"Gene Name\": \"CYP2C19\",\n",
      "\"CPIC Guideline Name\": \"Clinical Pharmacogenetics Implementation Consortium (CPIC) Guideline for CYP2C19 and Proton Pump Inhibitor Dosing (August 2020).pdf\",\n",
      "\"Content to Search\": \"Dosing adjustments for dexlansoprazole in CYP2C19 poor metabolizers\"\n",
      "}\n",
      "}\n",
      "]\n",
      "}\n",
      "\n",
      "**Begin processing immediately upon receiving inputs.**\n",
      "Drugs: dexlansoprazole, esomeprazole, lansoprazole, omeprazole, pantoprazole, rabeprazole\n",
      "Genes: CYP2C19\n",
      "CPIC guideline: Clinical Pharmacogenetics Implementation Consortium (CPIC) Guideline for CYP2C19 and Proton Pump Inhibitor Dosing (August 2020).pdf\n",
      "\n"
     ]
    }
   ],
   "source": [
    "\n",
    "# --- 主程式執行區 ---\n",
    "\n",
    "# 使用之前修正好的 Prompt 模板\n",
    "final_prompt_template = \"\"\"\n",
    "## CPIC QA Dataset Generator\n",
    "You are a pharmacogenomics expert creating structured QA datasets from CPIC guidelines. Follow this protocol:\n",
    "\n",
    "#### 1. Question Generation Requirements\n",
    "- **Exclusively generate drug-gene interaction questions**\n",
    "- **Question structure**:  \n",
    "  \"How does [Gene] affect [Drug] therapy?\"  \n",
    "  Rephrase the question to focus on the drug-gene interaction, or information .\n",
    "- **Key requirements**:  \n",
    "  - Questions MUST require CPIC guideline consultation  \n",
    "\n",
    "#### 2. Answer Format Specification\n",
    "{{\n",
    "\"Drug Name\": \"[Exact drug name from guideline]\",\n",
    "\"Gene Name\": \"[Standard gene nomenclature]\",\n",
    "\"CPIC Guideline Name\": \"[Full guideline title with publication date].pdf\",\n",
    "\"Content to Search\": \"[Text specifying the missing clinical information(parameters, guidance, dosage recommendation, etc.)requiring guideline search]\"\n",
    "}}\n",
    "- **Content to Search rules**:  \n",
    "  - Specify the missing clinical information(parameters, guidance, dosage recommendation, etc.)requiring guideline search and contributing to answer the question\n",
    "\n",
    "\n",
    "#### 3. Processing Workflow\n",
    "**Step 1: Process drug-gene pairs**  \n",
    "- For each combination in input lists:  \n",
    "  (Drug, Gene) → Generate QA pair\n",
    "\n",
    "**Step 2: Generate QA pairs per combination**  \n",
    "\n",
    "**Step 3: Format output**  \n",
    "{{\n",
    "\"[Exact Guideline Title].pdf\": [\n",
    "{{\n",
    "\"question\": \"How does CYP2C19 affect dexlansoprazole therapy?\",\n",
    "\"answer\": {{\n",
    "\"Drug Name\": \"Dexlansoprazole\",\n",
    "\"Gene Name\": \"CYP2C19\",\n",
    "\"CPIC Guideline Name\": \"Clinical Pharmacogenetics Implementation Consortium (CPIC) Guideline for CYP2C19 and Proton Pump Inhibitor Dosing (August 2020).pdf\",\n",
    "\"Content to Search\": \"Dosing adjustments for dexlansoprazole in CYP2C19 poor metabolizers\"\n",
    "}}\n",
    "}}\n",
    "]\n",
    "}}\n",
    "\n",
    "**Begin processing immediately upon receiving inputs.**\n",
    "Drugs: {csv_drug_name}\n",
    "Genes: {csv_gene_name}\n",
    "CPIC guideline: {csv_guideline_name}\n",
    "\"\"\"\n",
    "\n",
    "# 指定您的 CSV 檔案路徑\n",
    "csv_file_path = \"Guideline_Drug_Gene pair - Sheet1.csv\" \n",
    "\n",
    "# 生成28個版本的 Prompts\n",
    "generated_prompts = create_prompts_from_template_and_csv(final_prompt_template, csv_file_path)\n",
    "\n",
    "# 驗證並印出結果\n",
    "if generated_prompts:\n",
    "    print(f\"成功根據最終模板生成了 {len(generated_prompts)} 個 Prompt 版本。\\n\")\n",
    "    \n",
    "    # 印出一個包含多個藥物的 Prompt 作為範例，以檢視換行符號是否被成功替換\n",
    "    # (此處選擇第5個 Prompt，它對應質子幫浦抑制劑，有多個藥物)\n",
    "    print(\"--- Prompt 範例 (第 5 個版本)，檢視換行符號處理 ---\")\n",
    "    print(generated_prompts[4])"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 9,
   "id": "06202181",
   "metadata": {},
   "outputs": [],
   "source": [
    "# save prompts to a text file\n",
    "with open(\"generated_prompts.txt\", \"w\") as f:\n",
    "    for i, prompt in enumerate(generated_prompts):\n",
    "        f.write(f\"--- Prompt 版本 {i+1} ---\\n\")\n",
    "        f.write(prompt + \"\\n\")\n",
    "        f.write(\"=\"*40 + \"\\n\")"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 40,
   "id": "df629b1c",
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "總共有 28 個指引。\n",
      "總共有 387 個問題。\n"
     ]
    }
   ],
   "source": [
    "import json\n",
    "# read in dataset.txt, it's a list of dictionary\n",
    "\n",
    "# raed the dataset directly from list of dictionary\n",
    "dataset = []\n",
    "with open(\"dataset.txt\", \"r\") as f:\n",
    "    dataset = json.load(f)\n",
    "    \n",
    "\n",
    "# total number of questions\n",
    "guideline_num = 0\n",
    "q_num = 0\n",
    "for data in dataset:\n",
    "    for key, value in data.items():\n",
    "        guideline_num += 1\n",
    "        q_num += len(value)\n",
    "print(f\"總共有 {guideline_num} 個指引。\")\n",
    "print(f\"總共有 {q_num} 個問題。\")\n",
    "    "
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 6,
   "id": "a75e53b6",
   "metadata": {},
   "outputs": [],
   "source": [
    "creative_prompt_template = \"\"\"\n",
    "## CPIC QA Dataset Generator\n",
    "You are a pharmacogenomics expert creating structured QA datasets from CPIC guidelines. Follow this protocol:\n",
    "\n",
    "#### 1. Question Generation Requirements\n",
    "- **Exclusively generate drug-gene interaction questions**\n",
    "- **Question Structure**:\n",
    "  Design questions to extract specific clinical decision-making information. Below are the required question types with purposes, content targets, and examples:\n",
    "\n",
    "  1. **Specific Dosing Guidance**  \n",
    "     - *Purpose*: Extract precise drug dosage values and adjustment protocols  \n",
    "     - *Content to Search*: Dosage numbers, adjustment protocols, clinical recommendations  \n",
    "     - *Example*: \"What is the recommended efavirenz dose for a CYP2B6 poor metabolizer?\"  \n",
    "\n",
    "  2. **Clinical Risk Stratification**  \n",
    "     - *Purpose*: Obtain quantified adverse reaction risk data  \n",
    "     - *Content to Search*: Risk multipliers, incidence rates, toxicity thresholds  \n",
    "     - *Example*: \"What is the increased risk of CNS adverse effects for a CYP2B6 poor metabolizer?\"  \n",
    "\n",
    "  3. **Pharmacokinetics/Pharmacodynamics Data**  \n",
    "     - *Purpose*: Gather therapeutic drug monitoring values  \n",
    "     - *Content to Search*: Plasma concentration ranges, therapeutic windows  \n",
    "     - *Example*: \"What is the suggested therapeutic range for plasma efavirenz concentrations?\"  \n",
    "\n",
    "  4. **Genotype-Phenotype Correspondence**  \n",
    "     - *Purpose*: Clarify genotype to metabolic phenotype mapping  \n",
    "     - *Content to Search*: Diplotype definitions, phenotype categories  \n",
    "     - *Example*: \"What diplotypes define a CYP2B6 intermediate metabolizer?\"  \n",
    "\n",
    "  5. **Gene/Drug Basic Information**  \n",
    "     - *Purpose*: Provide foundational mechanistic definitions  \n",
    "     - *Content to Search*: Gene functions, drug mechanisms, enzyme roles  \n",
    "     - *Example*: \"What is the function of the CYP2B6*6 allele?\"  \n",
    "\n",
    "  6. **Special Population Dosing**  \n",
    "     - *Purpose*: Extract dosing for special populations  \n",
    "     - *Content to Search*: Pediatric/pregnancy dosing, comorbidity adjustments  \n",
    "     - *Example*: \"What is the dosing recommendation for efavirenz in children weighing <40kg with CYP2B6 poor metabolizer phenotype?\"  \n",
    "\n",
    "#### 2. Answer Format Specification\n",
    "{{\n",
    "\"Drug Name\": \"[Exact drug name from guideline]\",\n",
    "\"Gene Name\": \"[Standard gene nomenclature]\",\n",
    "\"CPIC Guideline Name\": \"[Full guideline title with publication date].pdf\",\n",
    "\"Content to Search\": \"[Text specifying missing clinical parameters/guidance requiring guideline search]\"\n",
    "}}\n",
    "\n",
    "#### 3. Processing Workflow\n",
    "**Step 1: Process drug-gene pairs**  \n",
    "- For each combination in input lists:  \n",
    "  (Drug, Gene) → Generate 1 QA pair per question type  \n",
    "\n",
    "**Step 2: Generate QA pairs**  \n",
    "- Each guideline with multiple drugs and genes will create #drug times #gene QA pairs\n",
    "- Each drug-gene combination will generate 6 QA pairs (one for each question type)  \n",
    "- Ensure phenotype specificity (poor/intermediate/ultrarapid metabolizers)  \n",
    "\n",
    "**Step 3: Format output**  \n",
    "{{\n",
    "\"[Exact Guideline Title].pdf\": [\n",
    "{{\n",
    "\"question\": \"How should omeprazole dosing be adjusted for CYP2C19 poor metabolizers?\",\n",
    "\"answer\": {{\n",
    "\"Drug Name\": \"Omeprazole\",\n",
    "\"Gene Name\": \"CYP2C19\",\n",
    "\"CPIC Guideline Name\": \"Clinical Pharmacogenetics Implementation Consortium (CPIC) Guideline for CYP2C19 and Proton Pump Inhibitor Dosing (August 2020).pdf\",\n",
    "\"Content to Search\": \"Dose adjustment protocol for omeprazole in CYP2C19 poor metabolizers\"\n",
    "}}\n",
    "}},\n",
    "{{\n",
    "\"question\": \"What is the toxicity risk for CYP2C19 poor metabolizers taking omeprazole?\",\n",
    "\"answer\": {{\n",
    "\"Drug Name\": \"Omeprazole\",\n",
    "\"Gene Name\": \"CYP2C19\",\n",
    "\"CPIC Guideline Name\": \"Clinical Pharmacogenetics Implementation Consortium (CPIC) Guideline for CYP2C19 and Proton Pump Inhibitor Dosing (August 2020).pdf\",\n",
    "\"Content to Search\": \"Quantified risk data for adverse effects in CYP2C19 PMs using omeprazole\"\n",
    "}}\n",
    "}}\n",
    "// Additional QA pairs for other question types\n",
    "]\n",
    "}}\n",
    "\n",
    "**Begin processing immediately upon receiving inputs.**\n",
    "Drugs: {csv_drug_name}\n",
    "Genes: {csv_gene_name}\n",
    "CPIC guideline: {csv_guideline_name}\n",
    "\"\"\"\n",
    "\n",
    "# 指定您的 CSV 檔案路徑\n",
    "csv_file_path = \"Guideline_Drug_Gene pair - Sheet1.csv\" \n",
    "\n",
    "# 生成28個版本的 Prompts\n",
    "generated_prompts = create_prompts_from_template_and_csv(creative_prompt_template, csv_file_path)\n",
    "\n",
    "# save prompts to a text file\n",
    "with open(\"generated_prompts.txt\", \"w\") as f:\n",
    "    for i, prompt in enumerate(generated_prompts):\n",
    "        f.write(f\"--- Prompt 版本 {i+1} ---\\n\")\n",
    "        f.write(prompt + \"\\n\")\n",
    "        f.write(\"=\"*40 + \"\\n\")"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 10,
   "id": "3a4f7188",
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "for Guideline: Clinical Pharmacogenetics Implementation Consortium (CPIC) Guidelines for Ivacaftor Therapy in the Context of CFTR Genotype (March 2014).pdf, we'll have 6 questions.\n",
      "for Guideline: Clinical Pharmacogenetics Implementation Consortium (CPIC) Guideline for CYP2B6 and Efavirenz-containing Antiretroviral Therapy (April 2019).pdf, we'll have 6 questions.\n",
      "for Guideline: Clinical Pharmacogenetics Implementation Consortium Guideline for CYP2B6 Genotype and Methadone Therapy (July 2024).pdf, we'll have 6 questions.\n",
      "for Guideline: Clinical Pharmacogenetics Implementation Consortium Guideline for CYP2C19 Genotype and Clopidogrel Therapy: 2022 update (January 2022).pdf, we'll have 6 questions.\n",
      "for Guideline: Clinical Pharmacogenetics Implementation Consortium (CPIC) Guideline for CYP2C19 and Proton Pump Inhibitor Dosing (August 2020).pdf, we'll have 36 questions.\n",
      "for Guideline: Clinical Pharmacogenetics Implementation Consortium (CPIC) Guideline for CYP2C19 and Voriconazole Therapy (December 2016).pdf, we'll have 6 questions.\n",
      "for Guideline: Clinical Pharmacogenetics Implementation Consortium (CPIC) Guideline for CYP2C9 and NSAID Therapy (March 2020).pdf, we'll have 168 questions.\n",
      "for Guideline: Clinical Pharmacogenetics Implementation Consortium (CPIC) Guidelines for CYP2C9 and HLA-B Genotype and Phenytoin Dosing (August 2020).pdf, we'll have 24 questions.\n",
      "for Guideline: Clinical Pharmacogenetics Implementation Consortium (CPIC) Guidelines for Pharmacogenetics-guided Warfarin Dosing: 2016 Update.pdf, we'll have 18 questions.\n",
      "for Guideline: Clinical Pharmacogenetics Implementation Consortium (CPIC) Guideline for CYP2D6 Genotype and Atomoxetine (February 2019).pdf, we'll have 6 questions.\n",
      "for Guideline: Clinical Pharmacogenetics Implementation Consortium (CPIC) Guideline for CYP2D6 Genotype and Use of Ondansetron and Tropisetron (December 2016).pdf, we'll have 12 questions.\n",
      "for Guideline: Clinical Pharmacogenetics Implementation Consortium (CPIC) Guideline for CYP2D6 and Tamoxifen Therapy (January 2018).pdf, we'll have 6 questions.\n",
      "for Guideline: Clinical Pharmacogenetics Implementation Consortium (CPIC) Guidelines for UGT1A1 and Atazanavir Prescribing (September 2015).pdf, we'll have 6 questions.\n",
      "for Guideline: Clinical Pharmacogenetics Implementation Consortium (CPIC) Guidelines for CYP3A5 genotype and Tacrolimus Dosing (July 2015).pdf, we'll have 6 questions.\n",
      "for Guideline: Clinical Pharmacogenetics Implementation Consortium (CPIC) Guideline for Dihydropyrimidine Dehydrogenase Genotype and Fluoropyrimidine Dosing: 2017 Update (October 2017).pdf, we'll have 18 questions.\n",
      "for Guideline: Clinical Pharmacogenetics Implementation Consortium (CPIC) Guideline for HLA Genotype and Use of Carbamazepine and Oxcarbazepine: 2017 Update (December 2017).pdf, we'll have 24 questions.\n",
      "for Guideline: Clinical Pharmacogenetics Implementation Consortium Guidelines for HLA-B Genotype and Abacavir Dosing (April 2012).pdf, we'll have 6 questions.\n",
      "for Guideline: Clinical Pharmacogenetics Implementation Consortium (CPIC) Guidelines for Human Leukocyte Antigen-B (HLA-B) Genotype and Allopurinol Dosing (February 2013).pdf, we'll have 6 questions.\n",
      "for Guideline: Clinical Pharmacogenetics Implementation Consortium (CPIC) Guideline for MT-RNR1 and Aminoglycosides (May 2021).pdf, we'll have 66 questions.\n",
      "for Guideline: Clinical Pharmacogenetics Implementation Consortium (CPIC) guideline for the use of potent volatile anesthetic agents and succinylcholine in the context of RYR1 or CACNA1S genotypes.pdf, we'll have 84 questions.\n",
      "for Guideline: Clinical Pharmacogenetics Implementation Consortium (CPIC) Guidelines for IFNL3 (IL28B) Genotype and PEG interferon-alpha-based Regimens (February 2014).pdf, we'll have 36 questions.\n",
      "for Guideline: Clinical Pharmacogenetics Implementation Consortium Guidelines for thiopurine dosing based on TPMT and NUDT15 genotypes: 2018 Update (November 2018).pdf, we'll have 36 questions.\n",
      "for Guideline: Clinical Pharmacogenetics Implementation Consortium Guideline (CPIC®) for CYP2D6 and CYP2C19 Genotypes and Dosing of Tricyclic Antidepressants: 2016 Update (December 2016).pdf, we'll have 84 questions.\n",
      "for Guideline: Clinical Pharmacogenetics Implementation Consortium (CPIC) guideline for CYP2D6, OPRM1, and COMT genotype and select opioid therapy (December 2020).pdf, we'll have 252 questions.\n",
      "for Guideline: The Clinical Pharmacogenetics Implementation Consortium (CPIC) guideline for SLCO1B1, ABCG2, and CYP2C9 and statin-associated musculoskeletal symptoms (January 2022).pdf, we'll have 252 questions.\n",
      "for Guideline: Expanded Clinical Pharmacogenetics Implementation Consortium (CPIC) Guideline for Medication Use in the Context of G6PD Genotype (August 2022).pdf, we'll have 288 questions.\n",
      "for Guideline: Clinical Pharmacogenetics Implementation Consortium (CPIC) Guideline for CYP2D6, ADRB1, ADRB2, ADRA2C, GRK4, and GRK5 Genotypes and Beta-Blocker Therapy (July 2024).pdf, we'll have 468 questions.\n",
      "for Guideline: Clinical Pharmacogenetics Implementation Consortium (CPIC) Guideline for CYP2D6, CYP2C19, CYP2B6, SLC6A4, and HTR2A Genotypes and Serotonin Reuptake Inhibitor Antidepressants (April 2023).pdf, we'll have 390 questions.\n",
      "總共有 28 個指引。\n",
      "總共有 2322 個問題。\n"
     ]
    }
   ],
   "source": [
    "import json\n",
    "# read in dataset.txt, it's a list of dictionary\n",
    "\n",
    "# raed the dataset directly from list of dictionary\n",
    "dataset = []\n",
    "# with open(\"creative_dataset_check.txt\", \"r\") as f:\n",
    "with open(\"creative_dataset.txt\", \"r\") as f:\n",
    "    dataset = json.load(f)\n",
    "    \n",
    "\n",
    "# total number of questions\n",
    "guideline_num = 0\n",
    "q_num = 0\n",
    "for data in dataset:\n",
    "    for key, value in data.items():\n",
    "        guideline_num += 1\n",
    "        print(f\"for Guideline: {key}, we'll have {len(value)} questions.\")\n",
    "        q_num += len(value)\n",
    "print(f\"總共有 {guideline_num} 個指引。\")\n",
    "print(f\"總共有 {q_num} 個問題。\")\n",
    "    "
   ]
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "id": "482c23dd",
   "metadata": {},
   "outputs": [],
   "source": [
    "with open(\"negative_sample_v1.txt\", \"r\") as f:\n",
    "    # read in as a list\n",
    "    \n",
    "\n",
    "    negative_sample = json.load(f)\n",
    "negative_sample[0] "
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 9,
   "id": "b29dbf84",
   "metadata": {},
   "outputs": [
    {
     "ename": "NameError",
     "evalue": "name 'dataset' is not defined",
     "output_type": "error",
     "traceback": [
      "\u001b[31m---------------------------------------------------------------------------\u001b[39m",
      "\u001b[31mNameError\u001b[39m                                 Traceback (most recent call last)",
      "\u001b[36mCell\u001b[39m\u001b[36m \u001b[39m\u001b[32mIn[9]\u001b[39m\u001b[32m, line 3\u001b[39m\n\u001b[32m      1\u001b[39m guideline_num = \u001b[32m0\u001b[39m\n\u001b[32m      2\u001b[39m q_num = \u001b[32m0\u001b[39m\n\u001b[32m----> \u001b[39m\u001b[32m3\u001b[39m \u001b[38;5;28;01mfor\u001b[39;00m data \u001b[38;5;129;01min\u001b[39;00m \u001b[43mdataset\u001b[49m:\n\u001b[32m      4\u001b[39m     \u001b[38;5;28;01mfor\u001b[39;00m key, value \u001b[38;5;129;01min\u001b[39;00m data.items():\n\u001b[32m      5\u001b[39m         guideline_num += \u001b[32m1\u001b[39m\n",
      "\u001b[31mNameError\u001b[39m: name 'dataset' is not defined"
     ]
    }
   ],
   "source": [
    "guideline_num = 0\n",
    "q_num = 0\n",
    "for data in dataset:\n",
    "    for key, value in data.items():\n",
    "        guideline_num += 1\n",
    "        q_num += len(value)\n",
    "print(f\"總共有 {guideline_num} 個指引。\")\n",
    "print(f\"總共有 {q_num} 個問題。\")"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 8,
   "id": "b25864ca",
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "{'question': 'What is the CPIC-recommended dose for metformin in a patient with the CYP2D6 *4/*4 genotype?',\n",
       " 'answer': 'No CPIC guideline information available.'}"
      ]
     },
     "execution_count": 8,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "import ast\n",
    "\n",
    "path = \"negative_sample.txt\"\n",
    "negative_sample = []\n",
    "\n",
    "\n",
    "with open(path, \"r\") as f:\n",
    "    # read in as a list\n",
    "    negative_sample = ast.literal_eval(f.read())\n",
    "\n",
    "negative_sample[0]"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 13,
   "id": "f549fd18",
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "dict_keys(['Clinical Pharmacogenetics Implementation Consortium (CPIC) Guidelines for Ivacaftor Therapy in the Context of CFTR Genotype (March 2014).pdf'])"
      ]
     },
     "execution_count": 13,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "dataset[0].keys()"
   ]
  }
 ],
 "metadata": {
  "kernelspec": {
   "display_name": "PGx_data_clean",
   "language": "python",
   "name": "python3"
  },
  "language_info": {
   "codemirror_mode": {
    "name": "ipython",
    "version": 3
   },
   "file_extension": ".py",
   "mimetype": "text/x-python",
   "name": "python",
   "nbconvert_exporter": "python",
   "pygments_lexer": "ipython3",
   "version": "3.11.13"
  }
 },
 "nbformat": 4,
 "nbformat_minor": 5
}
